Functionalization of nanoceria a dual approach to anticancer and antifungal applications
Source abstract
Abstract
Cerium oxide nanoparticles (CeO 2 NPs) have unique physicochemical properties that make them suitable for various applications, particularly in biomedicine. To enhance their compatibility with biological systems, we functionalized these nanoparticles with selected amino acids, which significantly improved their potential for biomedical use, as our findings show. Cerium oxide has a fluorite-type structure and can exist in both trivalent and tetravalent states. Notably, cerium oxide also serves as an effective radioprotectant, offering selective protection to normal cells over tumor cells. The present embodiment provides functionalized cerium oxide nanoflakes with a plurality of amino acids. The surface modification by amino acids has been studied and characterized with various techniques. The cytotoxicity and the biological activity of nanoceria and the functionalization of nanoceria were evaluated. The result of this investigation shows the change in morphology structure and optical properties. The anticancer activity of the samples shows significant results against the MCF-7 and SCC-29B cell lines overall. In the case of comparing pure and functionalized nanoceria in the microbial study, the functionalization of nanoceria shows better significance by improving biological activity in some cases than synthesized/pure nanoceria and becomes suitable for biomedical applications. Therefore, the results show that the functionalization of nanoceria plays an important role in manufacturing and the possibility of using it as a therapeutic compound in the future to improve the public health of society.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoparticles: synthesis and applications · Carbon and Quantum Dots Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Physics, Hodeidah University, Al Hudaydah, Yemen
Department of Physics, Dr Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, India
References (84)
Show source-provided references
1. 10.1007/s00253-005-0179-310.1007/s00253-005-0179-3 ↗
2. 10.1007/s10832-004-5179-710.1007/s10832-004-5179-7 ↗
3. 10.1016/S0925-8388(00)00603-410.1016/S0925-8388(00)00603-4 ↗
4. 10.1016/j.jphotobiol.2010.09.00210.1016/j.jphotobiol.2010.09.002 ↗
5. 10.1016/S1002-0721(14)60486-510.1016/S1002-0721(14)60486-5 ↗
6. 10.1021/acsami.6b0733810.1021/acsami.6b07338 ↗
7. 10.1016/j.biomaterials.2006.11.03610.1016/j.biomaterials.2006.11.036 ↗
8. 10.1038/nnano.2006.9110.1038/nnano.2006.91 ↗
9. 10.1016/j.cardiores.2006.11.03110.1016/j.cardiores.2006.11.031 ↗
10. 10.1039/b615134e10.1039/b615134e ↗
11. 10.1021/nl052024f10.1021/nl052024f ↗
12. 10.2147/IJN.S19419210.2147/IJN.S194192 ↗
13. 10.1002/jcp.2730310.1002/jcp.27303 ↗
14. 10.1039/c0cc01832e10.1039/c0cc01832e ↗
15. 10.3390/ijms1402306510.3390/ijms14023065 ↗
16. 10.1016/j.biomaterials.2012.11.06110.1016/j.biomaterials.2012.11.061 ↗
17. 10.1016/j.nano.2010.01.01010.1016/j.nano.2010.01.010 ↗
18. 10.1088/0957-4484/20/11/11510310.1088/0957-4484/20/11/115103 ↗
19. 10.1038/nmat244210.1038/nmat2442 ↗
20. 10.1021/nn100816s10.1021/nn100816s ↗
21. 10.1089/ars.2012.483110.1089/ars.2012.4831 ↗
22. https://www.who.int/health-topics/cancer#tab=tab_1
23. 10.21769/BioProtoc.198410.21769/BioProtoc.1984 ↗
24. ShakkeelaYusuf KK, Harindran J. Saudi J Med Pharm Sci 2017; 3: 323–327.
25. 10.3390/antiox1309109510.3390/antiox13091095 ↗
26. 10.1201/978131581501510.1201/9781315815015 ↗
27. 10.1016/j.biomaterials.2012.06.10410.1016/j.biomaterials.2012.06.104 ↗
28. 10.1021/acs.bioconjchem.7b0045510.1021/acs.bioconjchem.7b00455 ↗
29. 10.3390/nano1002024210.3390/nano10020242 ↗
30. 10.1093/jnci/82.13.110710.1093/jnci/82.13.1107 ↗
31. 10.1038/nprot.2006.17910.1038/nprot.2006.179 ↗
32. Singh S, Verma SK, Singh SK. In vitro investigation of anti-cancer potential of Spilanthes acmella. J Pharm Sci Res 2020; 12: 124–128.
33. 10.1016/j.saa.2020.11901010.1016/j.saa.2020.119010 ↗
34. 10.1016/j.jpha.2015.11.00510.1016/j.jpha.2015.11.005 ↗
35. 10.26502/jnr.2688-852100210.26502/jnr.2688-8521002 ↗
36. Yaseen SA, Alameen AS, Saif FA, et al. Synthesis of flake-like nanoceria, functionalization, and evaluation of their biological activity in vitro. J Ind Chem Soc 2025; 102: 101754.
37. 10.1016/j.dwt.2024.10090910.1016/j.dwt.2024.100909 ↗
38. 10.1039/C8NJ03393E10.1039/C8NJ03393E ↗
39. 10.1155/2015/25475010.1155/2015/254750 ↗
40. 10.1016/j.ceramint.2020.01.20210.1016/j.ceramint.2020.01.202 ↗
41. 10.1021/jp103146510.1021/jp1031465 ↗
42. 10.3390/nano710032610.3390/nano7100326 ↗
43. 10.1016/j.impact.2018.03.00110.1016/j.impact.2018.03.001 ↗
44. 10.1007/s10967-007-7255-310.1007/s10967-007-7255-3 ↗
45. 10.1021/acs.jpcc.6b0615810.1021/acs.jpcc.6b06158 ↗
46. 10.1039/C7RA12385J10.1039/C7RA12385J ↗
47. 10.1016/j.colsurfa.2006.05.00610.1016/j.colsurfa.2006.05.006 ↗
48. 10.1021/cm061332r10.1021/cm061332r ↗
49. 10.1016/j.molstruc.2006.01.00410.1016/j.molstruc.2006.01.004 ↗
50. Schrader B (ed.). Infrared and Raman spectroscopy: methods and applications. John Wiley & Sons, 2008.
51. 10.1002/047001114910.1002/0470011149 ↗
52. 10.1016/j.apsusc.2013.09.06710.1016/j.apsusc.2013.09.067 ↗
53. 10.3762/bjnano.8.24110.3762/bjnano.8.241 ↗
54. 10.3390/polym1207144410.3390/polym12071444 ↗
55. 10.1016/B978-0-323-90006-5.00006-910.1016/B978-0-323-90006-5.00006-9 ↗
56. Jagadeeshan S, Parsanathan R. Metal oxides as anticancer agents. Metal, metal oxides and metal sulphides for biomedical applications. Environmental chemistry for a sustainable world. Springer, 2021.
57. 10.1016/j.bcab.2020.10157910.1016/j.bcab.2020.101579 ↗
58. 10.1038/srep2768910.1038/srep27689 ↗
59. Giri S, Karakoti A, Graham RP, et al. PLoS One 2013; 8: e54578.
60. Sridharan M, Kamaraj P, Arockiaselvi J, et al. Mater Today 2021; 36: 914–919.
61. Sanaye M, Pagare N. Evaluation of antioxidant effect and anticancer activity against human glioblastoma (U373MG) cell lines of Murraya Koenigii. Pharm J 2016; 8.
62. Abdi Goushbolagh N, Abedi Firouzjah R, Ebrahimnejad Gorji K, et al. Artif Cells Nanomed Biotechnol 2018; 46: S1215–S1225.10.1080/21691401.2018.1536062 ↗
63. 10.1155/2019/715682810.1155/2019/7156828 ↗
64. 10.1007/s13399-023-04604-z10.1007/s13399-023-04604-z ↗
65. 10.1007/s11468-024-02591-z10.1007/s11468-024-02591-z ↗
66. 10.1016/j.molstruc.2023.13669510.1016/j.molstruc.2023.136695 ↗
67. 10.1016/j.jddst.2024.10570810.1016/j.jddst.2024.105708 ↗
68. 10.2147/OTT.S6205710.2147/OTT.S62057 ↗
69. Diaconeasa Z, Barbu-Tudoran L, Coman C, et al. Rom Biotechnol Lett 2015; 20: 10679.
70. 10.1007/s13399-023-04562-610.1007/s13399-023-04562-6 ↗
71. 10.1016/j.inoche.2023.11091310.1016/j.inoche.2023.110913 ↗
72. 10.1016/j.inoche.2023.11098210.1016/j.inoche.2023.110982 ↗
73. 10.1002/jso.293052020510.1002/jso.2930520205 ↗
74. Chavan R, Khan M, Sathe N, et al. Int Ayurv Med J 2016; 4: 66–70.
75. 10.3402/nano.v1i0.535810.3402/nano.v1i0.5358 ↗
76. 10.1007/s11095-012-0679-710.1007/s11095-012-0679-7 ↗
77. 10.1016/j.cbi.2015.03.01310.1016/j.cbi.2015.03.013 ↗
78. 10.22271/tpr.2019.v6.i2.02410.22271/tpr.2019.v6.i2.024 ↗
79. 10.1201/EBK143980419310.1201/EBK1439804193 ↗
80. 10.1007/s40843-019-9471-710.1007/s40843-019-9471-7 ↗
81. 10.1016/j.heliyon.2024.e4010410.1016/j.heliyon.2024.e40104 ↗
82. 10.1016/j.rechem.2021.10024510.1016/j.rechem.2021.100245 ↗
83. 10.1007/s11696-022-02072-910.1007/s11696-022-02072-9 ↗
84. 10.1016/j.rechem.2022.10050010.1016/j.rechem.2022.100500 ↗